InterCure Ltd.
INCR · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic
3.79USD-0.19 (-4.77%)
Price History
Full chartMarket Stats
Previous Close3.98
Open4.03
Day Range3.76 – 4.03
52-Week Range3.40 – 8.45
Volume3.00K
Market Cap78.17M
P/E (TTM)0.00
Forward P/E6.18
EPS-1.08
Dividend Yield0.00%
Beta0.59
50-Day Avg5.03
200-Day Avg4.74
About
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Company Details
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Alexander Rabinovich
- Employees285
- Headquarters85 Medinat ha-Yehudim Street, Herzliya, Israel, 4676670, USA
- Websitehttps://www.intercure.co
Leadership
- Mr. Alexander RabinovichFounder, CEO & Chairman · b. 1971
- Mr. Amos CohenChief Financial Officer · b. 1979
- Ms. Einat ZehaviChief Executive Officer of Retail
- Mr. Omer LayaniChief Technology Officer
- Mr. Yarin LidorHead of Marketing
- Mr. Dean SimhonHead of Supply Chain
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Market Cap78.17M
Enterprise Value127.29M
Trailing P/E0.00
Forward P/E6.18
Price / Sales0.66
Price / Book0.62
EPS-1.08
Book Value7.59
Revenue (TTM)243.12M
Gross Profit (TTM)40.61M
EBITDA-55.34M
Profit Margin-13.22%
Operating Margin0.00%
Return on Equity-9.27%
Return on Assets-5.78%
Shares Outstanding15.00M
Shares Float7.86M
Beta0.59
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%
Ownership Breakdown
- Institutions
- 1.05%
- Insiders
- 39.17%
- Retail / Other
- 59.78%
Top Fund Holders
- Fidelity Nasdaq Composite Index20.36K0.03%
Stock Splits
- Aug 24, 20261:5
- Apr 8, 2021946:4209